{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:25:00Z","timestamp":1788870300860,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Spanish CICYT","award":["SAF2012-39760-C02-01"],"award-info":[{"award-number":["SAF2012-39760-C02-01"]}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"crossref","award":["P2010\/BMD-2457"],"award-info":[{"award-number":["P2010\/BMD-2457"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.ejmech.2014.09.093","type":"journal-article","created":{"date-parts":[[2014,9,30]],"date-time":"2014-09-30T20:47:40Z","timestamp":1412110060000},"page":"421-428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Synthesis and antiproliferative activity of 6-phenylaminopurines"],"prefix":"10.1016","volume":"87","author":[{"given":"Mar\u00eda-Dolores","family":"Canela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Liekens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda-Jos\u00e9","family":"Camarasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Mar\u00eda","family":"Priego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1336-7760","authenticated-orcid":false,"given":"Mar\u00eda-Jes\u00fas","family":"P\u00e9rez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2014.09.093_bib1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrc1317","article-title":"Microtubules as target for anticancer drugs","volume":"4","author":"Jordan","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2014.09.093_bib2","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nrd3253","article-title":"Microtubule-binding agents: a dynamic field of cancer therapeutics","volume":"9","author":"Dumontet","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2014.09.093_bib3","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1158\/1535-7163.MCT-09-0366","article-title":"Microtubule inhibitors: differentiating tubulin-inhibiting agents based on mechanism of action, clinical activity and resistance","volume":"8","author":"P\u00e9rez","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejmech.2014.09.093_bib4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/med.20242","article-title":"Drugs that target dynamic microtubules: a new molecular perspective","volume":"31","author":"Stanton","year":"2011","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2014.09.093_bib5","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/PL00000912","article-title":"From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance","volume":"58","author":"Litman","year":"2001","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2014.09.093_bib6","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/sj.bjc.6605489","article-title":"Class III beta-tubulin expression and in\u00a0vitro resistance to microtubule targeting agents","volume":"102","author":"Stengel","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejmech.2014.09.093_bib7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2009.11.012","article-title":"Polyester-based micelles and nanoparticles for the parenteral delivery of taxanes","volume":"2","author":"Gaucher","year":"2010","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.ejmech.2014.09.093_bib8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nature02393","article-title":"Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain","volume":"428","author":"Ravelli","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2014.09.093_bib9","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1007\/s11095-012-0828-z","article-title":"An overview of tubulin inhibitors that interact with the colchicine binding site","volume":"29","author":"Lu","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejmech.2014.09.093_bib10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/med.20097","article-title":"Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin","volume":"28","author":"Bhattacharyya","year":"2008","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2014.09.093_bib11","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/15563650.2010.495348","article-title":"Colchicine poisoning: the dark side of an ancient drug","volume":"48","author":"Finkelstein","year":"2010","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.ejmech.2014.09.093_bib12","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1055\/s-0030-1250073","article-title":"Microtubule-binding natural products for cancer therapy","volume":"76","author":"Yue","year":"2010","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2014.09.093_bib13","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1158\/1078-0432.CCR-0642-03","article-title":"Vascular targeting agents as cancer therapeutics","volume":"10","author":"Thorpe","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2014.09.093_bib14","doi-asserted-by":"crossref","first-page":"11520","DOI":"10.1158\/0008-5472.CAN-06-2848","article-title":"Pathophysiologic effects of vascular-targeting agents and the implications for combination with conventional therapies","volume":"66","author":"Horsman","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2014.09.093_bib15","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.1158\/0008-5472.CAN-07-0127","article-title":"MPC-6827: a small-molecule inhibitor of microtubule formation that is not a substrate for multidrug resistance pumps","volume":"67","author":"Kasibhatla","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2014.09.093_bib16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11060-012-0964-7","article-title":"Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme","volume":"110","author":"Grossmann","year":"2012","journal-title":"J.\u00a0Neurooncol."},{"key":"10.1016\/j.ejmech.2014.09.093_bib17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11060-014-1437-y","article-title":"A\u00a0phase 2 trial of verubulin for recurrent glioblastoma: a prospective study by the brain tumor investigational consortium (BTIC)","volume":"118","author":"Chamberlain","year":"2014","journal-title":"J.\u00a0Neurooncol."},{"key":"10.1016\/j.ejmech.2014.09.093_bib18","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1021\/jm801315b","article-title":"Discovery of N-(4-methoxyphenyl)-N,2-dimethylquinazolin-4-amine, a potent apoptosis inducer and efficacious anticancer agent with high blood brain barrier penetration","volume":"52","author":"Sirisoma","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.09.093_bib19","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1016\/j.bmcl.2010.01.155","article-title":"Discovery of N-methyl-4-(4-methoxyanilino)quinazolines as potent apoptosis inducers. Structure\u2013activity relationship of the quinazoline ring","volume":"20","author":"Sirisoma","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.09.093_bib20","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/cmdc.201300531","article-title":"Effects of the tumor-vasculature-disrupting agent verubulin and two heteroaryl analogues on cancer cells, endothelial cells, and blood vessels","volume":"9","author":"Mahal","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2014.09.093_bib21","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1021\/jm4016526","article-title":"Optimization of 4-(N-cycloamino)phenylquinazolines as a novel class of tubulin-polymerization inhibitors targeting the colchicine site","volume":"57","author":"Wang","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.09.093_bib22","doi-asserted-by":"crossref","first-page":"8116","DOI":"10.1021\/jm101010n","article-title":"Synthesis and discovery of water-soluble microtubule targeting agents that bind to the colchicine site on tubulin and circumvent Pgp mediated resistance","volume":"53","author":"Gangjee","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.09.093_bib23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ddtec.2004.10.009","article-title":"Scaffold hoping","volume":"1","author":"B\u00f6hm","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.ejmech.2014.09.093_bib24","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cbpa.2010.02.018","article-title":"Privileged scaffolds for library design and drug discovery","volume":"14","author":"Welsch","year":"2010","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ejmech.2014.09.093_bib25","unstructured":"ChemBioDraw 12.0 (CambridgeSoft, Inc)."},{"key":"10.1016\/j.ejmech.2014.09.093_bib26","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.1021\/jm400305d","article-title":"Selective cannabinoid receptor type 2 (CB2) agonists: optimization of a series of purines leading to the identification of a clinical candidate for the treatment of osteoarthritic pain","volume":"56","author":"Hollinshead","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.09.093_bib27","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1021\/cc800169d","article-title":"Microwave-assisted synthesis of 9-arylpurines","volume":"11","author":"Aguado","year":"2009","journal-title":"J.\u00a0Comb. Chem."},{"key":"10.1016\/j.ejmech.2014.09.093_bib28","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1021\/jm901240p","article-title":"9-Arylpurines as a novel class of enterovirus inhibitors","volume":"53","author":"Aguado","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.09.093_bib29","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ejmech.2012.01.022","article-title":"Efficient synthesis and anti-enteroviral activity of 9-arylpurines","volume":"49","author":"Aguado","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.09.093_bib30","unstructured":"F. Janssens, L. Kennis, J. Hens, J. Torremans, G. Diels, 4-[(Bicycle heterocyclyl)-methyl and -hetero]-piperidines, US 4695575 A (1987)."},{"key":"10.1016\/j.ejmech.2014.09.093_bib31","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1007\/s11095-012-0816-3","article-title":"Novel water soluble, substituted pyrrolo[3,2-d]pyrimidines: design, synthesis and biological evaluation as antitubulin antitumor agents","volume":"29","author":"Gangjee","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejmech.2014.09.093_bib32","unstructured":"S.A. Campos, L.A. Harrison, N.J. Parr, K.P. Vipulkumar, G. Vitulli, 1,1-Dioxido-2,3-dihydro-1,2-benzisothiazol-6-yl-1H-indazol-4-yl-2,4-pyrimidinediamine derivatives, WO 2007009681 A1 (2007)."},{"key":"10.1016\/j.ejmech.2014.09.093_bib33","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejmech.2012.10.001","article-title":"Novel 1,4-benzoxazine and 1,4-benzodioxine inhibitors of angiogenesis","volume":"58","author":"Ili\u0107","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.09.093_bib34","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1021\/jm401939g","article-title":"Novel colchicine-site binders with a cyclohexanedione scaffold identified through a ligand-based virtual screening approach","volume":"57","author":"Canela","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.09.093_bib35","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1124\/mol.106.026559","article-title":"The nucleotide analog cidofovir suppresses basic fibroblast growth factor (FGF2) expression and signaling and induces apoptosis in FGF2-overexpressing endothelial cells","volume":"71","author":"Liekens","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2014.09.093_bib36","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/10408363.2012.738808","article-title":"DNA damage signaling assessed in individual cells in relation to the cell cycle phase and induction of apoptosis","volume":"49","author":"Darzynkiewicz","year":"2012","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.ejmech.2014.09.093_bib37","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1002\/ejoc.200800627","article-title":"Synthetic studies directed towards agelasine analogs \u2013 synthesis, tautomerism, and alkylation of 2-substituted N-methoxy-9-methyl-9H-purin-6-amines","volume":"30","author":"Roggen","year":"2008","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2014.09.093_bib38","series-title":"Gaussian 09, Revision A.02","author":"Frisch","year":"2009"},{"key":"10.1016\/j.ejmech.2014.09.093_bib39","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/jcc.1161","article-title":"Rapid grid-based construction of the molecular surface and the use of induced surface charge to calculate reaction field energies: applications to the molecular systems and geometric objects","volume":"23","author":"Rocchia","year":"2002","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2014.09.093_bib40","doi-asserted-by":"crossref","first-page":"6507","DOI":"10.1021\/jp010454y","article-title":"Extending the applicability of the nonlinear Poisson-Boltzmann equation: multiple dielectric constants and multivalent ions","volume":"105","author":"Rocchia","year":"2001","journal-title":"J.\u00a0Phys. Chem. B"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523414009210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523414009210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T04:39:16Z","timestamp":1589258356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523414009210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":40,"alternative-id":["S0223523414009210"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2014.09.093","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and antiproliferative activity of 6-phenylaminopurines","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2014.09.093","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}